EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Daily Orange Consumption Reduces Hepatic Steatosis Prevalence in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: Exploratory Outcomes of a Randomized Clinical Trial

Maria Notarnicola iD, Valeria Tutino, Valentina De Nunzio iD, Anna Maria Cisternino iD, Miriam Cofano iD, Rossella Donghia iD, Vito Giannuzzi, Marianna Zappimbulso, Rosa Anna Milella iD, Gianluigi Giannelli iD, Luigi Fontana

Nutrients · 20.09.2024 · 16 (18) · 3191

DOI: 10.3390/nu16183191 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 20.09.2024. Verfasst von Maria Notarnicola und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Nutritional Biochemistry, National Institute of Gastroenterology-IRCCS "Saverio de Bellis", Castellana Grotte, 70013 Bari, Italy. Hauptthemen laut MEDLINE: Citrus sinensis. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, Italian Ministry of Health Ricerca Corrente 2024.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Consumption of flavonoid-rich orange juice has been shown to reduce adiposity and liver steatosis in murine models of diet-induced obesity. However, little is known about the effects of whole orange intake, independent of body weight changes, on liver function and steatosis in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD). The goal is to understand the direct impact of orange consumption on metabolic health.

Methods

Sixty-two men and women aged 30–65 with MASLD (Controlled Attenuation Parameter, (CAP) > 275 dB/m) were randomly assigned to consume either 400 g of whole oranges or non-citrus fruits daily for 4 weeks. Baseline evaluations included medical assessments, blood tests, and body composition. Liver health was assessed using transient elastography (FibroScan®) for steatosis and fibrosis, conducted by blinded personnel. This clinical trial was registered at ClinicalTrials.gov (NCT05558592).

Results

After 4 weeks of orange supplementation, liver steatosis decreased in the treatment group, with 70.9% showing steatosis compared to 100% in controls (p < 0.004), indicating a 30% reduction in liver disease prevalence. There were no significant changes in fibrosis or plasma liver enzymes, though plasma gamma glutaril transferase (GGT) levels decreased significantly. Body weight, waist circumference, body composition, lipid profile, fasting glucose, insulin, and C-reactive protein levels remained unchanged. Dietary analysis revealed no change in caloric intake, but vitamins C, A, thiamine, and riboflavin increased in the orange group.

Conclusions

Our findings suggest that phytochemical-rich foods, especially whole fruits like oranges, may enhance liver function as an adjunct treatment for MASLD. The notable reduction in liver steatosis prevalence occurred independently of body weight changes. Further studies are needed to investigate the long-term effects of orange supplementation on steatosis and fibrosis progression and to identify the specific bioactive compounds and mechanisms involved.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Citrus sinensisHumansMaleMiddle AgedFemaleAdultAgedPrevalenceFatty LiverLiverFruit and Vegetable JuicesElasticity Imaging TechniquesFruitNon-alcoholic Fatty Liver Disease

Stichwörter der Autor:innen

CAPMASLDorangesphytochemical foodsteatosis

Autor:innen und Institutionen

  • Laboratory of Nutritional Biochemistry, National Institute of Gastroenterology-IRCCS "Saverio de Bellis", Castellana Grotte, 70013 Bari, Italy.
  • Ambulatory of Clinical Nutrition, National Institute of Gastroenterology-IRCCS "Saverio de Bellis", Castellana Grotte, 70013 Bari, Italy.
  • Data Science Unit, National Institute of Gastroenterology-IRCCS "Saverio de Bellis", Castellana Grotte, 70013 Bari, Italy.
  • Unit of Gastroenterology, National Institute of Gastroenterology-IRCCS "Saverio de Bellis", Castellana Grotte, 70013 Bari, Italy.
  • Research Centre for Viticulture and Enology, 70010 Turi, Italy.
  • Scientific Direction National Institute of Gastroenterology-IRCCS "Saverio de Bellis", Castellana Grotte, 70013 Bari, Italy.

ORCID-Profile: Maria Notarnicola, Valentina De Nunzio, Anna Maria Cisternino, Miriam Cofano, Rossella Donghia, Rosa Anna Milella, Gianluigi Giannelli

Förderung

  • Italian Ministry of Health
  • Italian Ministry of Health Ricerca Corrente 2024

Zitieren

APA

Notarnicola, M., Tutino, V., De Nunzio, V., Cisternino, A. M., Cofano, M., Donghia, R., Giannuzzi, V., Zappimbulso, M., Milella, R. A., Giannelli, G., & Fontana, L. (2024). Daily Orange Consumption Reduces Hepatic Steatosis Prevalence in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: Exploratory Outcomes of a Randomized Clinical Trial. Nutrients, 16(18), 3191. https://doi.org/10.3390/nu16183191

Vancouver

Notarnicola M, Tutino V, De Nunzio V, Cisternino AM, Cofano M, Donghia R, et al. Daily Orange Consumption Reduces Hepatic Steatosis Prevalence in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: Exploratory Outcomes of a Randomized Clinical Trial. Nutrients. 2024;16(18):3191. doi:10.3390/nu16183191

BibTeX
@article{Notarnicola2024,
  author = {Notarnicola, Maria and Tutino, Valeria and De Nunzio, Valentina and Cisternino, Anna Maria and Cofano, Miriam and Donghia, Rossella and Giannuzzi, Vito and Zappimbulso, Marianna and Milella, Rosa Anna and Giannelli, Gianluigi and Fontana, Luigi},
  title = {Daily Orange Consumption Reduces Hepatic Steatosis Prevalence in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: Exploratory Outcomes of a Randomized Clinical Trial},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {18},
  pages = {3191},
  doi = {10.3390/nu16183191}
}
Kostenlos starten →